Early Inflammatory Bowel Disease Progression

NCT06756100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2025-01-01

No results posted yet for this study

Summary

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Conditions

  • Inflammatory Bowel Diseases
  • Crohn Disease (CD)
  • Ulcerative Colitis (UC)

Sponsors & Collaborators

  • Fondo Nacional de Desarrollo CientÃ-fico y Tecnológico, FONDECYT (Chile).

    collaborator UNKNOWN
  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Cristian Hernández-Rocha, MD · Pontificia Universidad Catolica of chile

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-07
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06756100 on ClinicalTrials.gov